SCHEMBL21168538

SCHEMBL21168538

c1ccc(-c2cc(-c3ccccc3)nc(-c3cccc(-c4cccc5c4-c4ccccc4C54c5ccccc5-c5c(-c6cccc(-c7cc(-c8ccccc8)cc(-c8ccccc8)n7)c6)cccc54)c3)c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 6/20 0.40
CYP19A1 P11511 1/20 0.40
MEN1 O00255 5/20 0.38
KMT2A Q03164 5/20 0.38
RAB9A P51151 1/20 0.38
ADORA1 P30542 3/20 0.38
ADORA2A P29274 2/20 0.38
MAPT P10636 3/20 0.36
LMNA P02545 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
ADORA3 P0DMS8 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
MAPK10 P53779 1/20 0.36
ALDH1A1 P00352 2/20 0.36
HPGD P15428 2/20 0.36
KDM4E B2RXH2 1/20 0.36
AGTR1 P30556 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21168536 0.96 MEN1 (0.39) PDK2CYP19A1MEN1KMT2ARAB9A
SCHEMBL23873846 0.94 PDK2 (0.38) PDK2CYP19A1MEN1KMT2ARAB9A
SCHEMBL17031673 0.94 PDK2 (0.38) PDK2CYP19A1MEN1KMT2ARAB9A
SCHEMBL22646600 0.94 CYP1A1 (0.37) PDK2CYP19A1MEN1KMT2ARAB9A
SCHEMBL22077620 0.93 PDK2 (0.39) PDK2CYP19A1MEN1KMT2ARAB9A
SCHEMBL21578583 0.93 PDK2 (0.40) PDK2CYP19A1MEN1KMT2ARAB9A
SCHEMBL22073950 0.93 PDK2 (0.40) PDK2CYP19A1MEN1KMT2ARAB9A
SCHEMBL17031675 0.93 MEN1 (0.39) PDK2CYP19A1MEN1KMT2ARAB9A
SCHEMBL22646781 0.92 CYP1A1 (0.36) PDK2CYP19A1MEN1KMT2ARAB9A
SCHEMBL22074135 0.92 PDK2 (0.40) PDK2CYP19A1MEN1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230126748-A1 POLYMER, A COMPOSITION, AND AN ELECTROLUMINESCENT DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-04-27 US disclosed
US-20230126748-A1 POLYMER, A COMPOSITION, AND AN ELECTROLUMINESCENT DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-04-27 US disclosed
US-11233200-B2 Condensed cyclic compound, composition including the same, and organic light-emitting device including the condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2022-01-25 US disclosed
US-20200212306-A1 QUANTUM DOT ELECTROLUMINESCENCE DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-07-02 US disclosed
US-20190221746-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11233200-B2 Condensed cyclic compound, composition including the same, and organic light-emitting device including the condensed cyclic compound CRY1, CRY2, MCM4 PDK2 2534/4885CYP19A1 159/4885MEN1 203/4885
US-20190221746-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND CRY1, CRY2, MCM4 PDK2 2534/4885CYP19A1 159/4885MEN1 203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.